| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;100:772-776.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
From the Departments of Pediatric Cardiology (T.K., J.R., J.V.), Cardiothoracic Surgery (T.K., B.A., H.H.S.), Cardiology and Angiology (P.F.K., W.H., L.E., G.B.), Anesthesia (W.G., A.E.M., H.V.), and Obstetrics (R.W.), University of Münster Medical School, Germany.
Correspondence to Thomas Kohl, MD, Departments of Pediatric Cardiology and Cardiothoracic Surgery, University of Münster Medical School, Albert Schweitzer Str 33, 48149 Münster, Germany. E-mail tkohl{at}muenster.de
| Abstract |
|---|
|
|
|---|
Methods and Results We studied a total of 10 fetal sheep (87 to 103 days of gestation; term=145 days). We entered the amniotic cavity using a percutaneous fetoscopic approach and placed various electrophysiology catheters into the fetal esophagus. We recorded the number of animals in which fetoscopic transesophageal electrocardiography and stimulation were successful and assessed pacing success and thresholds for different catheters. In addition, we monitored for potential adverse effects from stimulation and for other complications of the operation. Recording of transesophageal electrocardiograms was successful in all fetal sheep. Capture during stimulation was successfully documented by additional fetal bipolar surface electrocardiograms in 7 fetuses. In fetuses in which fetal surface electrocardiograms were not recorded, pacing stimulus artifacts interfered with documentation of capture. Although stimulation thresholds were high, the maternal rhythm was not affected by fetal stimulation.
ConclusionsFetoscopic fetal transesophageal electrocardiography and stimulation are feasible in fetal sheep. This minimally invasive approach might have the potential to improve diagnosis and management of therapy-refractory supraventricular tachycardias in human fetuses.
Key Words: tachycardia electrocardiography electrophysiology fetoscopy
| Introduction |
|---|
|
|
|---|
The poor prognosis of fetuses with therapy-refractory supraventricular tachycardia in cardiac failure has prompted interest in developing alternative treatment strategies to achieve tachycardia termination. Cryosurgical ablation of the atrioventricular node followed by long-term epicardial pacing through an open fetal operative approach has been performed in fetal sheep.6 However, this approach is associated with high maternal and fetal morbidity because it requires maternal laparotomy and hysterotomy as well as fetal thoracotomy. Hysterotomy for open operative procedures, however, uniformly results in premature delivery in human fetuses.7 In addition, cesarean section is obligatory after open fetal surgery for the treated as well as for any future child because of the risk of uterine rupture during normal delivery.8 Of greater concern, significant decreases in fetoplacental blood flow have been observed in human fetuses after open fetal surgery for diaphragmatic hernia.9 These flow changes may be particularly detrimental to a tachycardic fetus in cardiac failure. Furthermore, ablation of the atrioventricular node results in lifelong pacemaker dependency and associated problems. Because most tachycardia in the neonate/fetus is orthodromic reciprocating tachycardia with spontaneous resolution during the first year of life, the morbidity and mortality of atrioventricular nodal ablation seem excessive in the context of the natural history in these patients.10 11
In contrast to open fetal surgery, fetoscopic surgery does not require maternal laparotomy and hysterotomy. As a result, no maternal mortality or significant morbidity has been reported in a large multicenter series of 3000 diagnostic procedures in human fetuses.12 Recent studies in primates and sheep indicate that a minimally invasive fetoscopic approach also results in significantly less premature uterine contractions and less reduction in maternoplacental blood flow after the procedure.13 14 A minimally invasive fetoscopic approach that permits recording of fetal transesophageal electrocardiograms and cardiac stimulation with low operative risks to mother and fetus may enhance our understanding of the underlying electrophysiological mechanisms of therapy-refractory fetal tachycardias and permit more appropriate drug selection. Transesophageal electrocardiography and stimulation might be of similar value in the fetus than it has been in postnatal patient populations to diagnose and terminate tachycardias of supraventricular origin.15 16 Therefore, the purpose of our study in fetal sheep was to assess the feasibility of a minimally invasive fetoscopic approach for fetal transesophageal electrocardiography and stimulation.
| Methods |
|---|
|
|
|---|
|
Operative Fetoscopic Approach
We placed three to four 5-mm trocars (M.E.M., Madison, Conn)
into the amniotic cavity of each ewe by a percutaneous
technique using T-fasteners (Ross Product Division-Abbot
Laboratories, Columbus, Ohio).17 Whereas the first trocar
was placed by ultrasound guidance, subsequent trocars were placed under
direct fetoscopic visualization following amniotic fluid removal and
low-pressure (8 to 13 mm Hg) insufflation of the amniotic cavity.
Using fetoscopic instrumentation (Karl Storz GmbH, Tuttlingen,
Germany), we suspended the fetal head with a stay suture underneath the
anterior uterine wall. In 7 sheep, we advanced an 8F standard catheter
sheath into the fetal oropharynx. Head suspension and intraoral
catheter sheath insertion were performed to facilitate introduction and
exchange of various electrophysiological
catheters (quadripolar monophasic action potential - pacing combination
catheter, Boston Scientific Corporation; bipolar electrophysiology
catheter, Arrow Technologies; decapolar electrophysiology catheter,
BARD - Angiomed) (Table
). We measured the distance
between the fetal mouth and chest using laparoscopic instruments with
length markings and advanced the electrophysiology catheter until a
clear transesophageal ECG was recorded.
|
Recordings and Protocols
All electrophysiological signals
were preamplified, digitized (1 kHz sampling rate; maximum amplitude
voltage resolution <1%), and stored on optical disc for offline
analysis using a 32-channel electrophysiology system (LAB
System 2.57, BARD Electrophysiology). Transesophageal
stimulation was attempted between the 2 electrodes recording
the highest atrial signal amplitudes with a preselected impulse
duration of 10 ms using a high output stimulator (Osypka Pace 500D,
Sulzer Medica). Stimulus strengths varied between 10 and 150 mA. When
stimulation was not successful, stimulation was attempted using other
pairs of electrodes. Bipolar fetal surface
electrocardiograms were recorded in the last 7
sheep by placing laparoscopic instruments (n=4) or suturing standard
epicardial pacing wires (n=3) onto both fetal shoulders resembling
Einthoven lead I. A standard 6-lead ECG was recorded from each
ewe.
Study Variables and Statistical Analysis
We recorded the number of animals in which fetoscopic
transesophageal
electrocardiography and stimulation were
successful. We assessed pacing success for different catheters and the
threshold at high rate stimulation (300 bpm). We assessed adverse
effects on fetal and maternal rhythm during and after stimulation and
monitored for complications from the operation.
Following fetal electrocardiography and stimulation, we euthanized 5 ewes and their fetuses under deep anesthesia with potassium-chloride overdose. In these animals, fetal umbilical blood gases were taken. In the remaining 5 ewes, we filled the uterus with warmed saline containing antibiotics and closed the uterine trocar insertion sites by a percutaneous technique.17 These ewes and their fetuses recovered from surgery. The newborn lambs were observed for injury and neurological damage from the procedure. At autopsy, in both the short- and long-term studies, we inspected the maternal abdomen for bleeding or injury to other organs from the procedure and assessed adverse fetal effects from percutaneous access and transesophageal stimulation. The study protocol was approved by the local committee on animal research and was performed according to institutional guidelines.
| Results |
|---|
|
|
|---|
Pacing artifacts in the transesophageal
electrocardiograms were of high amplitude, thereby
precluding verification of local capture from this site. In the first 3
fetuses in which a surface ECG was not recorded, successful
stimulation could not be documented. Successful
transesophageal stimulation was documented in all
fetuses in the 7 fetuses in which surface
electrocardiograms were recorded
(Figure
).
Stimulation and the lowest stimulation thresholds (mean 48±26 mA) were
most reliably achieved using the decapolar catheter (Table
).
Using the decapolar catheter, the 2 electrodes showing the highest
amplitude in the transesophageal electrogram were used
as stimulation electrodes. Because simulation success was rarely
achieved and the MAP catheter was stiffer and larger than the other
catheters, it was not used in the last 3 experiments. Despite good
local electrocardiograms, the slim bipolar catheter
allowed for successful stimulation in only 3 of 7 fetuses
(Table
).
Apart from pacing artifacts, the maternal rhythm was not affected by fetal cardiac stimulation. All fetal sheep survived fetoscopic transesophageal electrocardiography and stimulation and were alive at the end of the procedure. In 4 of the 5 ewes that were acutely terminated after the procedure, umbilical arterial blood gases were normal. One of the 5 ewes that continued gestation aborted 1 week after the procedure. The 4 other ewes continued gestation and delivered between 127 and 146 days of gestation (mean=137.5 days; term=145 days). At autopsy, no damage to the esophagus at the stimulation site was observed after the short-term studies. In all fetuses, fetal head suspension and intraoral catheter sheath placement was achieved with negligible injury.
Complications
In one ewe, the maternal stomach was perforated with one of the
trocar tips and had to be repaired through a mini laparotomy. Another
ewe became hypotensive and bradycardic during the procedure and her
CO2 elimination decreased. Hypotension was
successfully treated by epinephrine administration and the
operation could be completed. This ewe delivered 2 lambs at 127 days of
gestation; the lamb that had undergone transesophageal
electrocardiography and stimulation had
developed a membranelike form of esophageal atresia superior to the
previous stimulation site and died from aspiration on the first day of
life. In addition, bilateral cerebral hemorrhage was found in
this lamb at autopsy. Histochemical staining revealed a fresh,
peripartal hemorrhage unrelated to prior fetal
electrocardiography and stimulation. Another
lamb died in the first hours of life following a protracted delivery at
142 days of gestation.
| Discussion |
|---|
|
|
|---|
Implications
Fetal transesophageal
electrocardiograms allowing discrimination between
atrial and ventricular activation can reliably and
reproducibly be obtained by our minimally invasive fetoscopic
technique. Similar to postnatal transesophageal
electrocardiographic studies, the prenatal approach should permit
assessment of the mechanism of tachycardia and
characterization of conduction properties in the
fetus.15 16 On the basis of the tachycardia
mechanism found, selection of specific drug treatment and drug testing
by stimulation seem possible. Temporary placement of the
intraesophageal electrophysiology catheter into the early postoperative
period may permit repetitive termination of tachycardia
relapses until the most effective drug therapy has been defined similar
to previous experiments in adults.18
Transesophageal
electrocardiography and stimulation may,
therefore, become useful diagnostic and therapeutic tools
for definition and termination of therapy-refractory
supraventricular tachycardias in fetuses.
In contrast, currently applied maternal transabdominal fetal echocardiography permits little differentiation among the various supraventricular tachycardias and, consequently, treatment has been empirical.19 20 21 Postnatal electrophysiological studies of newborns with previously known fetal tachycardia are limited by their retrospective nature and selection bias.22 23 Because the newborns analyzed in these studies belong to the group of survivors, the mechanisms of the most malignant tachycardias resulting in fetal demise might not be represented in these studies. Whereas tachycardia conversion is generally achieved in nonhydropic fetuses, fetuses with supraventricular tachycardia and hydrops respond less well to empirical antiarrhythmic therapy.1 21 22 23 24 25 26 Premature delivery of this subgroup of patients results in additional complications.4 5 Therefore, the mortality in this group has been considerable,1 and accurate definition of the underlying mechanism by fetal transesophageal electrocardiography and stimulation may be helpful.
Fetal transesophageal electrocardiography may also help to identify potentially dangerous drug effects. Fetal demise within 24 hours of antiarrhythmic drug administration has raised concerns about a direct relationship between drug and demise.1 27 Fetal monitoring by temporary fetal electrocardiograms may prove useful to recognize and counteract hazardous electrocardiographic changes indicating drug toxicity.
Technical Considerations
Percutaneous fetal access for intraesophageal
catheter placement and fetal surgical manipulation can reliably be
achieved by our previously described ultrasound and fetoscopic
techniques.17 28 29 Fetal head suspension combined with
intraoral placement of a standard catheter sheath facilitates
introduction and exchange of electrophysiology catheters.
Recording of complimentary fetal surface
electrocardiograms is necessary to confirm capture
because pacing stimuli artifacts notably interfere with
transesophageal electrocardiographic
recordings. Although local transesophageal
electrocardiograms could be recorded using all the
catheters tested, stimulation was better achieved by using multipolar
than bi- or quadripolar electrophysiology catheters (Table
).
Optimizing the stimulation technique in sheep fetuses may not apply to
human fetuses because of differences in torso-heart-esophagus
anatomy between both species. Despite these differences,
transesophageal
electrocardiography and stimulation of the
fetal heart may provide useful information about the functional
maturation of the cardiac conduction system.
Complications
In general, fetoscopic fetal
electrocardiography and stimulation has been
safe for the ewe and her fetus. Importantly, the maternal rhythm was
not affected by the high fetal pacing thresholds. Nevertheless, some
potentially serious maternal and fetal complications were encountered
during our early studies. These complications can be partly explained
by the step-by-step development of these experimental procedures.
In one ewe, the anterior stomach wall was perforated with one of the trocars during the fetal access procedure. In another ewe, marked hypotension was observed. Unattended, these complications can result in serious and intolerable maternal morbidity. Because maternal safety is paramount to any invasive fetal procedure, exclusion or treatment of any injury to maternal intra-abdominal contents by laparoscopy is important before the trocar insertion sites are closed. In addition, maternal monitoring during fetal procedures should follow established protocols.
All fetal sheep survived fetoscopic fetal transesophageal electrocardiography and stimulation and were alive at the end of the procedure. Normal umbilical blood gases obtained after 4 short-term studies provided the first evidence that, although time consuming, the minimally invasive fetoscopic approach does not result in serious compromises of maternoplacental and fetoplacental blood flows. Along with this finding, we did not observe any maternal or fetal neurological injuries attributable to the procedure. Bilateral cerebral bleeding in one fetus was clearly defined by histochemical staining as a peripartum event. Yet in one of our long-term studies, supracardiac esophageal atresia from intraesophageal catheter manipulation was observed at postnatal autopsy. This complication might have been due to mechanical trauma or thermal injury from stimulation. Therefore, immediate postpartum assessment of esophageal passage will be mandatory in any human fetus subjected to this procedure.
Limitations
This study has been performed in healthy fetuses and acute fetal
demise was not observed. In contrast, in tachycardic fetuses in severe
cardiac failure, the operative mortality of the procedure may be
higher. Nevertheless, we believe that the poor prognosis of this
subgroup of fetuses may justify the application of our technique as a
potential life-saving approach.
Conclusion
Our study demonstrates that fetoscopic fetal
transesophageal
electrocardiography and stimulation are
feasible in fetal sheep. This minimally invasive approach has the
potential to improve definition and management of therapy-refractory
supraventricular tachycardias in hydropic human
fetuses. Some potentially serious maternal and fetal complications
encountered in our early studies can be explained by the experimental
nature of these procedures and may be avoidable by enlarged operative
experience.
| Acknowledgments |
|---|
Received December 2, 1998; revision received April 8, 1999; accepted April 15, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. Kohl, J. Reckers, D. Strumper, M. Grosse Hartlage, W. Gogarten, U. Gembruch, J. Vogt, H. Van Aken, H. H. Scheld, W. Paulus, et al. Amniotic air insufflation during minimally invasive fetoscopic fetal cardiac interventions is safe for the fetal brain in sheep J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 467 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Krapp, T Kohl, J M Simpson, G K Sharland, A Katalinic, and U Gembruch Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia Heart, August 1, 2003; 89(8): 913 - 917. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |